OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
NDP response to cancer, healthcare inadequate: Kelowna BC United members

NDP response to cancer, healthcare inadequate: Kelowna BC United members

B.C. United recently released its ‘United to Fix Healthcare Patient Bill of Rights’ B.C. United MLA…

Continue Reading
BC United announces ‘Patient Bill of Rights’

BC United announces ‘Patient Bill of Rights’

BC United is committed to a new bill that would publicly fund treatments at private health-care…

Continue Reading
Hearing | Hearings | The United States Senate Committee on Finance

Hearing | Hearings | The United States Senate Committee on Finance

Full Committee Hearing Date: Wednesday, May 1, 2024 Time: 09:00 AM Location: 215 Dirksen Senate Office…

Continue Reading
United States Ultrasound Devices Market Trends and Forecast 2024-2030 with Recent Developments and Revenue Analysis of Key Players GE Healthcare, Healthcare Hologic, and Butterfly Network Among Others

United States Ultrasound Devices Market Trends and Forecast 2024-2030 with Recent Developments and Revenue Analysis of Key Players GE Healthcare, Healthcare Hologic, and Butterfly Network Among Others

Company Logo U.S. Ultrasound Devices Market U.S. Ultrasound Devices Market Dublin, March 21, 2024 (GLOBE NEWSWIRE)…

Continue Reading